SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently trending as investors debate its long-term viability, with a vocal segment of the community highlighting alternative meme tokens on other chains as more efficient options for supply burns and utility. Sentiment remains sharply divided between loyalists maintaining a long-term bullish outlook and skeptics who argue the token has lost its momentum and faces persistent downside pressure.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing market attention following the successful FDA approval of its Thyroid Eye Disease treatment, Lumvoa, prompting active community discussion around the company's commercialization strategy and competitive positioning against Amgen's Tepezza. Investors are closely monitoring analyst upgrades and the potential for a favorable long-term trajectory as the firm pivots into its commercial-stage roadmap.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent Biosolutions is experiencing significant volatility as investors monitor a series of new strategic manufacturing contracts and pending financial results, while community sentiment remains divided between those betting on a turnaround under CEO Joe Papa and skeptics wary of dilution and debt levels. Conversations are heavily focused on the company's ability to secure government biodefense contracts, its efforts to stabilize balance sheets, and the potential impact of various infectious disease outbreaks on long-term demand.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing significant upward momentum and trending interest as investors speculate on potential Russell 1000 index inclusion and position themselves ahead of anticipated mid-summer catalysts. The community remains hyper-focused on the company's proprietary cancer treatment technology, while simultaneously engaging in intense discussions about squeezing short sellers who remain heavily positioned against the stock.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor attention driven by CEO insider buying and a recent, large-scale asset-backed securitization that has stabilized liquidity. While the community is actively debating the stock's potential for a short squeeze amid heavy short interest, sentiment is polarized between those focused on the company's profitability and those frustrated by recent stock performance following its Russell index removal.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is currently facing high volatility as investors weigh the company's aggressive revenue growth projections against concerns regarding ongoing insider selling and share dilution. The community is sharply divided, with some traders viewing the current pullback as a buying opportunity based on AI infrastructure demand, while others caution that the stock is fundamentally overvalued and prone to further downside.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a significant upward revision to its fiscal year 2026 EBITDA guidance, which has reignited intense community speculation about a potential eBay acquisition and its long-term strategic transformation. The stock is currently being cross-referenced by retail traders alongside other high-short-interest names like Wendy's, with ongoing debates surrounding the feasibility of future short squeezes and the impact of CEO Ryan Cohen's recent moves.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is in the spotlight following strong quarterly results and the announcement of a four-for-one stock split, sparking intense debate among investors over whether the company's premium valuation remains justified. While the community highlights its role as a core cybersecurity leader, the stock has experienced significant volatility as traders weigh record-setting growth against high market expectations.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as a go-to anchor for investors looking to bypass volatile tech-heavy rotations and betting on the long-term compounding potential of the total U.S. stock market. The community remains focused on its structural role as a set-it-and-forget-it core holding, even as traders debate broader market risks, institutional volatility, and potential economic headwinds.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's ($WEN) is seeing intense retail interest as a potential short squeeze candidate, with investors highlighting its high short interest, deep-value fundamentals, and consistent dividend payments. The community is actively rallying around the stock with 'save Wendy' messaging, comparing its potential setup to past viral short squeezes while tracking institutional movements and upcoming business expansion plans.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JNJ Johnson &amp; Johnson (JNJ) may be one of the oldest names in healthcare, but its MedTech launches, innovative medicine portfolio, institutional backing, and AI-powered healthcare potential show why this blue-chip healthcare stock still deserves serious investor attention. https://biotechhealthx.com/biotech-news/is-johnson-johnson-jnj-still-one-of-the-safest-healthcare-stocks-to-buy/

Johnson & Johnson (NYSE) may be one of the oldest names in healthcare, but its MedTech launches, innovative medicine portfolio, institutional backing, and AI-powered healthcare potential show why this blue-chip healthcare stock still deserves serious investor attention.

BioTech Health X

Is Johnson & Johnson (JNJ) Still One of the Safest Healthcare Stocks to Buy?

StockTwits Web

Johnson & Johnson

 Johnson & Johnson (JNJ) may be one of the oldest names in healthcare, but its MedTech launches, innovative medicine portfolio, institutional backing, and AI-powered healthcare potential show why this blue-chip healthcare stock still deserves serious investor attention. 